이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

유방암 이력이 있는 여성을 위한 통합 영양 및 운동 중재

2026년 10월 2일 업데이트: Prof. Dr. Alejandro Martínez-Rodríguez, University of Alicante

유방암 병력이 있는 여성의 신체적, 생리적, 심리적 수준에서 식이-영양 전략과 운동 프로그램을 시행한 효과에 관한 연구

This study aims to evaluate the effects of a combined dietary-nutritional and physical exercise intervention on physical, physiological, and psychological outcomes in women who are breast cancer survivors. Participants will be randomly assigned to different intervention groups involving dietary modification, exercise training, or their combination, compared to a control group. The program will last 12 weeks and will include pre- and post-intervention assessments of body composition, metabolic parameters, functional capacity, and quality of life.

The primary goal is to assess improvements in physical fitness, body composition, and emotional well-being, as well as to identify potential synergistic effects of combined interventions in this population.

연구 개요

상태

완전한

정황

개입 / 치료

상세 설명

Breast cancer survivors often experience long-term physical and psychological side effects derived from treatment, such as fatigue, loss of muscle mass, metabolic alterations, and reduced quality of life. Lifestyle interventions involving nutrition and exercise have demonstrated significant potential to mitigate these effects and promote overall recovery.

This randomized controlled clinical trial will include adult female breast cancer survivors who have completed their primary oncological treatment. Participants will be divided into six parallel groups:

  1. Control group - no intervention.
  2. Mediterranean diet group (MD) - individualized nutritional plan based on Mediterranean dietary patterns.
  3. Strength training group (ST) - supervised resistance exercise sessions.
  4. Endurance training group (ET) - supervised aerobic exercise sessions.
  5. Combined training group (CT) - combination of strength and endurance training.
  6. Combined diet and exercise group (MD+CT) - simultaneous application of Mediterranean diet and combined training.

The intervention will last 12 weeks, during which participants in the intervention groups will attend supervised sessions and receive continuous nutritional guidance. Assessments will be performed at baseline and after 12 weeks, including anthropometric and body composition analysis, metabolic and inflammatory markers, physical fitness testing, dietary intake, and psychological well-being scales.

This study seeks to identify the most effective strategy-dietary, physical, or combined-for improving health outcomes, functionality, and emotional recovery in breast cancer survivors, contributing to the development of comprehensive post-treatment rehabilitation programs.

연구 유형

중재적

등록 (실제)

120

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Alicante
      • Elche, Alicante, 스페인, 03203
        • European Institute Of Exercise and Health

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

30년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Women aged 30 to 65 years.
  • Previous diagnosis of breast cancer (stages I-III) confirmed by medical records.
  • Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment.
  • Absence of active cancer or evidence of recurrence.
  • Medical clearance to perform physical exercise.
  • Willingness to participate in dietary and/or exercise interventions for 12 weeks.
  • Ability to attend evaluation and intervention sessions and comply with study procedures.
  • Signed written informed consent.

Exclusion Criteria:

  • Active cancer, metastasis, or ongoing chemotherapy or radiotherapy.
  • Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise.
  • Musculoskeletal or neurological conditions limiting participation in physical activity.
  • Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention.
  • Current participation in another clinical trial or structured lifestyle intervention.
  • Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period.
  • Pregnancy, breastfeeding, or intention to become pregnant during the study.
  • Inability to comply with the intervention schedule or follow-up assessments.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Arm 1 - Control Group

Participants will not receive any specific dietary or exercise intervention. They will be asked to maintain their usual lifestyle and dietary habits during the 12-week study period. General health recommendations based on national guidelines will be provided at baseline.

실험적: Arm 2 - Mediterranean Diet Group (MD)

Participants will receive individualized nutritional counseling promoting adherence to a Mediterranean dietary pattern, emphasizing fruits, vegetables, legumes, whole grains, olive oil, nuts, fish, and moderate dairy intake. Processed and high-sugar foods will be limited. Dietitians will provide personalized follow-up and adjustments every two weeks to ensure adherence.

Individualized nutritional counseling based on Mediterranean diet principles, emphasizing the intake of fruits, vegetables, legumes, whole grains, nuts, olive oil, and fish, while reducing red meat, processed foods, and added sugars. Sessions will be held biweekly to ensure adherence and promote long-term dietary behavior change.

실험적: Arm 3 - Strength Training Group (ST)

Participants will perform a 12-week supervised resistance training program focused on improving muscular strength and functional capacity. Sessions will be conducted three times per week, lasting approximately 60 minutes, and include major muscle groups using elastic bands, free weights, and bodyweight exercises. Training load will progressively increase according to individual capacity.

A structured resistance exercise program performed three times per week for 12 weeks. Each 60-minute session will include exercises for major muscle groups using elastic bands, dumbbells, or body weight, progressively increasing intensity to improve muscle strength and endurance.

실험적: Arm 4 - Endurance Training Group (ET)

Participants will follow a structured aerobic exercise program consisting of walking, cycling, or treadmill sessions three times per week for 12 weeks. The intensity will be moderate (60-75% of estimated maximal heart rate), gradually progressing as tolerated. The goal is to enhance cardiorespiratory fitness and overall endurance.

A structured aerobic exercise program consisting of walking, cycling, or treadmill training three times per week for 12 weeks. Exercise intensity will range from 60% to 75% of the estimated maximal heart rate, progressively adjusted to enhance cardiovascular fitness and fatigue resistance.

실험적: Arm 5 - Combined Training Group (CT)

Participants will perform both strength and aerobic training during the 12-week intervention. Each session (3 per week, 60-70 minutes) will include resistance exercises targeting major muscle groups followed by aerobic activity at moderate intensity. The program aims to improve both muscular and cardiovascular performance synergistically.

A combined exercise protocol including both resistance and aerobic components within each 60-70-minute session, three times per week for 12 weeks. Strength exercises will precede moderate-intensity aerobic work to improve overall physical performance and functional capacity.

실험적: Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)

Participants will simultaneously receive the Mediterranean Diet counseling and participate in the Combined Training program for 12 weeks. The objective is to assess the synergistic effects of diet and exercise on physical, physiological, and psychological health in breast cancer survivors.

Comprehensive lifestyle intervention combining Mediterranean diet counseling with the supervised combined training program. Participants will receive individualized diet plans and attend three supervised exercise sessions per week. The intervention targets improvements in body composition, physical fitness, and emotional well-being.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in Fat-Free Mass (kg)
기간: Baseline and Week 12

To evaluate changes in fat-free mass after the 12-week intervention, measured by bioimpedance analysis (BIODY XPERT ZM).

Baseline and Week 12

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Fat Mass (%)
기간: Baseline and Week 12

To assess changes in total body fat percentage using bioimpedance analysis.

Baseline and Week 12
Change in Body Weight (kg)
기간: Baseline and Week 12

To determine body weight variation during the 12-week intervention.

Baseline and Week 12
Change in Body Mass Index (kg/m²)
기간: Baseline and Week 12

To evaluate changes in BMI calculated as weight divided by height squared.

Baseline and Week 12
Change in Waist Circumference (cm)
기간: Baseline and Week 12

To assess central adiposity changes by measuring waist circumference.

Baseline and Week 12
Change in Handgrip Strength (kg)
기간: Baseline and Week 12

To evaluate upper-body muscular strength using a digital hand dynamometer.

Baseline and Week 12
Change in Lower-Limb Strength (kg)
기간: Baseline and Week 12

To assess lower-limb strength through isometric tests using a load cell or force platform.

Baseline and Week 12
Change in Functional Capacity (6-Minute Walk Test Distance, m)
기간: Baseline and Week 12

To evaluate cardiorespiratory endurance using the 6-minute walk test.

Baseline and Week 12
Change in Balance Performance
기간: Baseline and Week 12

To assess dynamic balance and postural control

Baseline and Week 12
Change in Flexibility (Sit-and-Reach Test, cm)
기간: Baseline and Week 12

To evaluate flexibility of the posterior chain through the sit-and-reach test.

Baseline and Week 12
Change in Maximal Oxygen Uptake (VO₂max, mL/kg/min)
기간: Baseline and Week 12

To determine changes in aerobic capacity using an incremental treadmill test with indirect calorimetry (METALYZ-ERR 3 B-R3 spirometer).

Baseline and Week 12
Change in Total Cholesterol (mg/dL)
기간: Baseline and Week 12

To evaluate lipid profile variations by measuring total cholesterol concentration.

Baseline and Week 12
Change in HDL Cholesterol (mg/dL)
기간: Baseline and Week 12

To assess cardioprotective lipid changes.

Baseline and Week 12
Change in LDL Cholesterol (mg/dL)
기간: Baseline and Week 12

To measure changes in LDL cholesterol levels.

Baseline and Week 12
Change in Triglycerides (mg/dL)
기간: Baseline and Week 12

To determine variations in triglyceride concentration.

Baseline and Week 12
Change in Fasting Glucose (mg/dL)
기간: Baseline and Week 12

To assess metabolic health by measuring fasting plasma glucose.

Baseline and Week 12
Change in C-Reactive Protein (mg/L)
기간: Baseline and Week 12

To evaluate systemic inflammation using CRP levels.

Baseline and Week 12
Change in Interleukin-6 (pg/mL)
기간: Baseline and Week 12

To measure inflammatory status via IL-6 concentration.

Baseline and Week 12
Change in Fatigue (FACIT-F Questionnaire Score)
기간: Baseline and Week 12

Description: Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F). This questionnaire consists of 13 items rated on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("very much"), reflecting fatigue experienced during the past 7 days. The total score is calculated by summing the item scores (after reverse scoring where applicable). Range: 0-52. Interpretation: Higher scores indicate less fatigue and therefore a better functional status, while lower scores reflect greater fatigue severity.

Baseline and Week 12
Change in Sleep Quality (PSQI Total Score)
기간: Baseline and Week 12

Description: Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-reported questionnaire that evaluates sleep quality and disturbances over the previous month. The items are grouped into seven components (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction), each scored from 0 to 3. The global PSQI score is the sum of the components (range 0-21). Range: 0-21. Interpretation: Higher scores indicate poorer sleep quality.

Baseline and Week 12
Change in Physical Activity Level (IPAQ Total Score)
기간: Baseline and Week 12

Description: Physical activity levels will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF), which records the frequency and duration of walking, moderate, and vigorous activities over the past 7 days. The results are expressed as total metabolic equivalent minutes per week (MET-min/week) and can be categorized into three levels: low, moderate, or high activity. Range: 0 to unlimited MET-min/week. Interpretation: Higher scores indicate higher physical activity levels.

Baseline and Week 12
Change in Dietary Adherence (Mediterranean Diet Adherence Screener Score)
기간: Baseline and Week 12

Description: Adherence to the Mediterranean diet will be assessed using the PREDIMED Questionnaire, a validated 14-item questionnaire evaluating key dietary habits such as olive oil use, fruit and vegetable consumption, fish intake, and limitation of red meat and sweets. Each affirmative answer scores 1 point, yielding a total score from 0 (minimal adherence) to 14 (maximal adherence). Range: 0-14. Interpretation: Higher scores indicate better adherence to the Mediterranean dietary pattern.

Baseline and Week 12

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2023년 9월 1일

기본 완료 (실제)

2025년 12월 31일

연구 완료 (실제)

2026년 6월 30일

연구 등록 날짜

최초 제출

2025년 11월 25일

QC 기준을 충족하는 최초 제출

2025년 12월 8일

처음 게시됨 (실제)

2025년 12월 10일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 10월 2일

마지막으로 확인됨

2026년 2월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • UA-2025-06-13

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .